PubMed=1770930
Murakami T., Nakamura M., Kusanagi H., Suzuki T.
Establishment and characterization of human esophageal carcinoma cell lines -- especially the role of the serum-free culture.
Nihon Geka Gakkai Zasshi 92:1563-1570(1991)

DOI=10.5833/jjgs.27.1885
Kusanagi H.
Effect of epidermal growth factor (EGF) on human esophageal cancer cell lines in a protein-free medium and the expression of EGF receptors on the cells.
Nihon Shokaki Geka Gakkai Zasshi 27:1885-1891(1994)

PubMed=8590302; DOI=10.1089/jir.1995.15.1005
Oka M., Hirose K., Iizuka N., Aoyagi K., Yamamoto K., Abe T., Hazama S., Suzuki T.
Cytokine mRNA expression patterns in human esophageal cancer cell lines.
J. Interferon Cytokine Res. 15:1005-1009(1995)

PubMed=8974001; DOI=10.1089/jir.1996.16.1001
Oka M., Iizuka N., Yamamoto K., Gondo T., Abe T., Hazama S., Akitomi Y., Koishihara Y., Ohsugi Y., Ooba Y., Ishihara T., Suzuki T.
The influence of interleukin-6 on the growth of human esophageal cancer cell lines.
J. Interferon Cytokine Res. 16:1001-1006(1996)

PubMed=18575732; DOI=10.3892/or.20.1.155
Kawaoka T., Oka M., Takashima M., Ueno T., Yamamoto K., Yahara N., Yoshino S., Hazama S.
Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
Oncol. Rep. 20:155-163(2008)

PubMed=20515944; DOI=10.1158/1535-7163.MCT-09-0918; PMCID=PMC2884061
Seki N., Toh U., Sayers T.J., Fujii T., Miyagi M., Akagi Y., Kusukawa J., Kage M., Shirouzu K., Yamana H.
Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.
Mol. Cancer Ther. 9:1842-1851(2010)